Elevance Health, Inc.
ELVHealthcareNASDAQHealthcare Plans · Last scanned Jul 18, 2026
Scan Results
Daily timeframeElevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. With a market capitalization of $80.92B, it sits in large-cap territory. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Market Cap
$80.92B
Beta
0.68
P/E (TTM)
16.50
P/E (Fwd)
12.58
EPS (TTM)
$22.61
EPS (Fwd)
$29.65
ROE
11.1%
ROA
3.8%
Cash
$37.51B
Total Debt
$31.04B
Free CF
$4.31B
52W Change
34.6%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $37.51B in cash comfortably exceeding the $31.04B debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow comes in at $4.31B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 11.1% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.8% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $156.59B (2022) to $199.12B (2025), reflecting a 27% increase over the period.
ELV's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ELV.